As of 2026-04-02, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -4.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 91.73 mil USD. MEIP's TTM EBITDA according to its financial statements is -21.71 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 17.1x | 15.2x |
| Forward P/E multiples | 17.2x - 21.8x | 20.0x |
| Fair Price | (10.81) - 11.37 | (0.30) |
| Upside | -452.2% - 270.2% | -109.8% |
| Date | EV/EBITDA |